Selank research in Canada examines the anxiolytic and immunomodulatory properties of this synthetic heptapeptide. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a hybrid peptide derived from tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro extension for metabolic stability. Canadian researchers study selank to understand GABAergic signalling, enkephalin metabolism, and immune system modulation in controlled laboratory settings.
GABAergic Research with Selank
Selank is studied for its influence on GABA-A receptor expression and enkephalinase activity. Research suggests selank may modulate the metabolism of enkephalins — endogenous opioid peptides involved in anxiety regulation. Canadian neuropharmacology researchers use selank to investigate these pathways in animal models.
Immune System Research
Selank’s parent compound tuftsin is a known immunomodulatory peptide. Canadian researchers study selank as an extension of tuftsin research, investigating its influence on interleukin expression, T-cell activity, and macrophage function in immune research protocols.
Stability Advantages for Research
The Pro-Gly-Pro extension added to the tuftsin sequence significantly increases selank’s stability in biological media, making it more practical for research protocols. This stability allows for consistent dosing in time-course experiments without rapid peptide degradation confounding results.
Sourcing Selank in Canada
Research-grade selank is available in Canada from EhBuddy Peptides. All batches are lab-tested for purity. Products are for laboratory research use only and are not intended for human or veterinary consumption.
Selank remains a valuable neuropeptide research tool in Canada for scientists studying anxiety signalling pathways and immune regulation at the molecular level.
